Trescot Andrea M, Datta Sukdeb, Lee Marion, Hansen Hans
University of Florida, Gainesville, FL 32606, USA.
Pain Physician. 2008 Mar;11(2 Suppl):S133-53.
BACKGROUND: Mu agonists have been an important component of pain treatment for thousands of years. The usual pharmacokinetic parameters (half-life, clearance, volume of distribution) of opioids have been known for some time. However, the metabolism has, until recently, been poorly understood, and there has been recent interest in the role of metabolites in modifying the pharmacodynamic response in patients, in both analgesia and adverse effects. A number of opioids are available for clinical use, including morphine, hydromorphone, levorphanol, oxycodone, and fentanyl. Advantages and disadvantages of various opioids in the management of chronic pain are discussed. OBJECTIVE: This review looks at the structure, chemistry, and metabolism of opioids in an effort to better understand the side effects, drug interactions, and the individual responses of patients receiving opioids for the treatment of intractable pain. CONCLUSION: Mu receptor agonists and agonist-antagonists have been used throughout recent medical history for the control of pain and for the treatment of opiate induced side effects and even opiate withdrawal syndromes.
背景:数千年来,μ阿片受体激动剂一直是疼痛治疗的重要组成部分。阿片类药物的常用药代动力学参数(半衰期、清除率、分布容积)已为人所知有一段时间了。然而,直到最近,其代谢情况仍知之甚少,并且最近人们对代谢产物在改变患者药效学反应(包括镇痛和不良反应)中的作用产生了兴趣。有多种阿片类药物可供临床使用,包括吗啡、氢吗啡酮、左啡诺、羟考酮和芬太尼。本文讨论了各种阿片类药物在慢性疼痛管理中的优缺点。 目的:本综述探讨阿片类药物的结构、化学和代谢,以便更好地理解接受阿片类药物治疗顽固性疼痛患者的副作用、药物相互作用及个体反应。 结论:在近代医学史上,μ受体激动剂和激动 - 拮抗剂一直被用于控制疼痛、治疗阿片类药物引起的副作用甚至阿片类药物戒断综合征。
Pain Physician. 2008-3
ChemMedChem. 2007-11
Exp Clin Psychopharmacol. 2006-2
Basic Clin Pharmacol Toxicol. 2008-11
Acta Anaesthesiol Belg. 2002
Anasthesiol Intensivmed Notfallmed Schmerzther. 2004-9
Expert Opin Drug Metab Toxicol. 2025-6-22
Int J Mol Sci. 2025-5-19
Front Med (Lausanne). 2025-4-11
Pharmaceuticals (Basel). 2025-3-11
Pharmaceutics. 2025-3-3
Curr Issues Mol Biol. 2025-3-18